Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
letaplimab (IBI188) / Innovent Biologics
NCT04485052: Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia	Suspended	1/2	222	RoW	IBI188, Azacitidine, Decitabine	Innovent Biologics (Suzhou) Co. Ltd.	Acute Myeloid Leukemia	06/24	12/24
NCT04485065: Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS	Suspended	1	120	RoW	IBI188+azacitidine	Innovent Biologics (Suzhou) Co. Ltd.	Myelodysplastic Syndromes	12/23	08/24